United Kingdom
  • Europe
  • News
  • UK
  • World
  • Business
  • Technology
  • Science
  • Entertainment
  • Sports
  • Health

Categories

  • Artificial intelligence
  • Arts and design
  • Birmingham
  • Books
  • Boxing
  • Brexit
  • Bristol
  • Britain
  • Business
  • Celebrities
  • Computing
  • Cricket
  • Cycling
  • Economy
  • Edinburgh
  • England
  • Entertainment
  • Entrepreneurship
  • Environment
  • EU
  • F1
  • Fitness
  • Football
  • France
  • Gadgets
  • Genetics
  • Germany
  • Glasgow
  • Golf
  • Health
  • Healthcare
  • Internet
  • Jobs
  • Leeds
  • Liverpool
  • London
  • Manchester
  • Markets
  • Medication
  • Mental health
  • Mobile
  • Movies
  • Music
  • News
  • Northern Ireland
  • Nutrition
  • Personal finance
  • Physics
  • Racing
  • Royals
  • Rugby
  • Russia
  • Science
  • Scotland
  • Sheffield
  • Space
  • Spain
  • Sports
  • Technology
  • Tennis
  • TV
  • UK
  • Ukraine
  • United Kingdom
  • United States
  • Virtual reality
  • Wales
  • Wildlife
  • World
United Kingdom
  • Europe
  • News
  • UK
  • World
  • Business
  • Technology
  • Science
  • Entertainment
  • Sports
  • Health

Browsing Tag

cognitive impairment

5 posts
MMedication
Common allergy medication’s risks outweigh its usefulness, experts say
Read More

Common allergy medication’s risks outweigh its usefulness, experts say

  • 2 August 2025
AND ON THE SEACOAST, 95 AND 101 ARE DELAY FREE. THIS CAN BE A TOUGH TIME OF YEAR…
MMedication
Common allergy medication’s risks outweigh its usefulness, experts say
Read More

Common allergy medication’s risks outweigh its usefulness, experts say

  • 2 August 2025
AND ON THE SEACOAST, 95 AND 101 ARE DELAY FREE. THIS CAN BE A TOUGH TIME OF YEAR…
MMedication
Common allergy medication’s risks outweigh its usefulness, experts say
Read More

Common allergy medication’s risks outweigh its usefulness, experts say

  • 2 August 2025
AND ON THE SEACOAST, 95 AND 101 ARE DELAY FREE. THIS CAN BE A TOUGH TIME OF YEAR…
MMental health
Recognify’s Phase IIb trial of schizophrenia therapy fails to meet primary goal
Read More

Recognify’s Phase IIb trial of schizophrenia therapy fails to meet primary goal

  • 29 July 2025
atai Life Sciences (ATAI) company Recognify Life Sciences has reported that its Phase IIb trial of oral compound,…
FFrance
France launches campaign to curb overuse of anxiety and sleep medications
Read More

France launches campaign to curb overuse of anxiety and sleep medications

  • 10 April 2025
Amid rising concern over long-term use and side effects, France has launched a national campaign to raise awareness…
United Kingdom
www.europesays.com